ANI Pharmaceuticals (ANIP)

[big bambino]

Ok, here is my take as best as possible.

1) 11 products to be launched in 2H
2)147 million cash on hand
3)67 products with approximately 4 billion IMS
4)48 products on faster approval track
5)North of 80% market on EEMT by end of 4Q
6)CBE products 250M IMS
7)1 PRODUCT HAS ONLY 1 COMPETITOR AND WILL LAUNCH IN 2016.

I Hope I relayed everything correctly. Hard to read chicken scratch scribble when not really sure of the pharmacological terms.